IQVIA™ Real-World Insights Bibliography

Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Latour M1, Gerega S2, Millson B2, Bessette L3, Marshall JK4, Lebovic G5,6, Sung M2, Oraichi D2, Gaetano T1, Gazel S1, Laliberté MC1
Affiliations(s): 1 AbbVie Corporation, St. Laurent, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada 4 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Publication(s):  American College of Gastroenterology 2016 Conference, October 14-19, Las Vegas, USA
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Gastrointestinal disorders, Medication compliance,
2016
  L:
A:
English
Database Study,
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Gerega S1, Millson B1, Bessette L2, Marshall JK3, Lebovic G4,5, Sung M1, Oraichi D1, Gaetano T6, Gazel S6, Latour M6, Laliberté MC6
Affiliations(s): 1 IMS Brogan, Kirkland, Quebec, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 4 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 5 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 6 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s):  American College of Rheumatology 2016 Annual Meeting, November 11-16, Washington DC, USA
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Medication compliance, Rheumatology,
2016
  L:
A:
English
Database Study,
  Add to report
 
 
Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy.
Author(s): Akinbosoye OE1, Taitel MS1, Grana J1, Hill J2, Wade RL2.
Affiliations(s): 1 Walgreen Co., Health Analysis Research and Reporting , Deerfield, Illinois. 2 IMS Health, Health Economics and Outcomes Research , Real World Solutions, Plymouth Meeting, Pennsylvania.
Publication(s):  Popul Health Manag. 2016 Dec;19(6):454-461
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Medication compliance,
2016
  L:
A:
English
Budget impact, Retrospective database analysis,
  Add to report
 
 
Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy.
Author(s): Akinbosoye OE1, Taitel MS1, Grana J1, Hill J2, Wade RL2.
Affiliations(s):  1 Walgreen Co., Health Analysis Research and Reporting , Deerfield, Illinois. 2 IMS Health, Health Economics and Outcomes Research , Real World Solutions, Plymouth Meeting, Pennsylvania.
Publication(s):  Popul Health Manag. 2016 Dec 1; 19(6): 454–461.
Document Type(s): Article,
Countries: USA,
C:
Y:
Medication compliance,
2016
  L:
A:
English
Budget impact, Retrospective database analysis,
  Add to report
 
 
Exploring innovative methods to identify patient subgroup treatment response
Author(s): J Rigg, M Hankins, A Roddam, A Avorn, J Kim
Affiliations(s): 
Publication(s):  31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 22-26, 2015. Hynes Convention Center Boston, MA USA.
Document Type(s): Conference,
Countries: England,
C:
Y:
Medication compliance, Methodology,
2015
  L:
A:
English
Methodology, Observational study,
  Add to report
 
 
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Author(s): Katsarava Z1,2, Ehlken B3, Limmroth V4, Taipale K5, Patel SN5, Niemczyk G5, Rehberg-Weber K5, Wernsdörfer C5; C.A.R.E. Study Group
Affiliations(s): 1 Department of Neurology, Evangelic Hospital Unna, Unna, Germany 2 Department of Neurology, University Hospital Essen, Essen, Germany 3 IMS HEALTH, Munich, Germany 4 Department of Neurology, Cologne City Hospitals, University of Cologne, Cologne, Germany 5 Biogen GmbH, Ismaning, Germany
Publication(s):  BMC Neurol. 2015 Sep 22;15(1):170.
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Medication compliance, Neurological disorders,
2015
  L:
A:
German
Cost analysis, Observational study, Prospective study,
  Add to report
 
 
Analysis of Etanercept Treatment Patterns and Reimbursement Gaps in Patients Transitioning From Private to Public Drug Plans (poster)
Author(s): Millson B1, Poulin-Costello M2, Garces K2
Affiliations(s): 1 IMS Health Canada Inc, Kirkland, QC, Canada 2 Amgen Canada, Mississauga, ON, Canada
Publication(s):  ISPOR Annual International Meeting 2015
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Medication compliance,
2015
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Comparison of Compliance and Discontinuation Rates Among MS Patients Treated with Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis
Author(s): Haddad P1, Duquette P2, Yeung M3, Lamarche AM1, Fraelic A4, Chan S4
Affiliations(s):  1Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, CANADA 2 Notre Dame Hospital, Université de Montréal, Montreal, Quebec, CANADA 3 University of Calgary, Multiple Sclerosis Clinic, Calgary, Alberta, CANADA 4 IMS Brogan, a unit of IMS Health Canada Inc., Montreal, Quebec, CANADA
Publication(s):  ISPOR Annual European Congress 2015
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Medication compliance,
2015
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Study of medication errors which may occur in the process of electronic prescription and dispensing using failure mode and effects analysis (FMEA)
Author(s): Toussi M1, Berthelot H2, Simon G2
Affiliations(s): 1 IMS Health, Paris, France 2 BDMC , C achan, France
Publication(s):  30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Oct 24-27, 2014, Taipei International Convention Center
Document Type(s): Poster,
Countries: 
C:
Y:
Medication compliance,
2014
  L:
A:
English
Database Study,
  Add to report
 
 
Off-Patent Generic Medicines vs Off-Patent Brand Medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardu Region of Italy
Author(s): Colombo G, Agabiti Rosei E, Margonato A, Mencacci C, Montecucco CM, Trevisan R
Affiliations(s): 1 Department of Drug Sciences, University of Pavia, Pavia, Italy, 2 S.A.V.E. Studi Analisi Valutazioni Economiche, Milan, Italy, 3 Division of Medicine and Surgery, Spedali Civili, Brescia, Italy, 4 Division of Cardiology, San Raffaele University Hospital, Milan, Italy, 5 Department of Neuroscience, A.O. Fatebenefratelli e Oftalmico, Milan, Italy, 6 Division of Rheumatology, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy, 7 Unit of Diabetology, Ospedali Riuniti di Bergamo, Bergamo, Italy
Publication(s):  PLoS One. 2013; 8(12): e82990.
Document Type(s): Article,
Countries: Italy,
Click here for the abstract
C:
Y:
Medication compliance,
2013
  L:
A:
English
Cost analysis, Retrospective cohort analysis,
  Add to report
 
 
First Page Previous Page  2 of 5 Next Page Last Page